JPWO2021162030A1 - - Google Patents
Info
- Publication number
- JPWO2021162030A1 JPWO2021162030A1 JP2022500439A JP2022500439A JPWO2021162030A1 JP WO2021162030 A1 JPWO2021162030 A1 JP WO2021162030A1 JP 2022500439 A JP2022500439 A JP 2022500439A JP 2022500439 A JP2022500439 A JP 2022500439A JP WO2021162030 A1 JPWO2021162030 A1 JP WO2021162030A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020021306 | 2020-02-12 | ||
| PCT/JP2021/004928 WO2021162030A1 (en) | 2020-02-12 | 2021-02-10 | Metabolite diagnostic biomarker for drug-induced interstitial pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021162030A1 true JPWO2021162030A1 (en) | 2021-08-19 |
Family
ID=77292323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500439A Pending JPWO2021162030A1 (en) | 2020-02-12 | 2021-02-10 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2021162030A1 (en) |
| WO (1) | WO2021162030A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014004539A1 (en) * | 2012-06-26 | 2014-01-03 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Metabolomics in pneumonia and sepsis |
| JP2017023090A (en) * | 2015-07-27 | 2017-02-02 | 国立大学法人神戸大学 | Method and kit for determining susceptibility of drug-induced interstitial pneumonia using marker for determining susceptibility of drug-induced interstitial pneumonia |
-
2021
- 2021-02-10 JP JP2022500439A patent/JPWO2021162030A1/ja active Pending
- 2021-02-10 WO PCT/JP2021/004928 patent/WO2021162030A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021162030A1 (en) | 2021-08-19 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20220530 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220530 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230925 |